EPISODE · May 17, 2026 · 9 MIN
Episode 4: A Rare Disease Breakthrough and Tirzepatide Meets Psoriasis
from Medicine Weekly with Del Parrish · host Del Parrish
This week I cover a phase 3 trial out of the New England Journal of Medicine on a first in class oral treatment for dermatomyositis, a rare and difficult to treat autoimmune disease, and a JAMA Dermatology study on combining a psoriasis biologic with tirzepatide, the drug class behind Mounjaro, to simultaneously treat psoriasis and obesity.Find Medicine Weekly with Del Parrish on Spotify and Apple Podcasts.
What this episode covers
This week I cover a phase 3 trial out of the New England Journal of Medicine on a first in class oral treatment for dermatomyositis, a rare and difficult to treat autoimmune disease, and a JAMA Dermatology study on combining a psoriasis biologic with tirzepatide, the drug class behind Mounjaro, to simultaneously treat psoriasis and obesity.Find Medicine Weekly with Del Parrish on Spotify and Apple Podcasts.
NOW PLAYING
Episode 4: A Rare Disease Breakthrough and Tirzepatide Meets Psoriasis
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m